Medication class
Sleep
Prescription and OTC sleep aids for insomnia, including benzodiazepine receptor agonists and melatonin receptor agonists.
Data updated 2026-05-15
- 10
- Medications
- 7
- With a generic
- 90%
- Avg generic savings
- 0
- In active shortage
Drug class assignments follow the FDA openFDA therapeutic classification, and clinical details are drawn from FDA Structured Product Labeling (DailyMed). See the full sources below.
PlainMeds tracks 10 sleep medications compiled from official FDA drug labels, including zolpidem, melatonin, temazepam.
Sleep medications are grouped here by the openFDA therapeutic classification and drawn from FDA Structured Product Labeling. PlainMeds lists 10 in this class, 7 with a lower-cost generic available (averaging about 90% versus brand). Each drug page covers labeled uses, FAERS-reported side effects, interactions, recalls and NADAC pricing. This is educational information from public data, not medical advice.
What sleep drugs cost
Highest NADAC acquisition cost per unit in this class, brand and generic
- tasimelteon
tasimelteon
$609 per unit
- eszopiclone $23
eszopiclone
$23 per unit
- zolpidem $21
zolpidem
$21 per unit
- suvorexant $14
suvorexant
$14 per unit
- ramelteon $12
ramelteon
$12 per unit
- lemborexant $11
lemborexant
$11 per unit
- triazolam $0
triazolam
$0 per unit
- zaleplon $0
zaleplon
$0 per unit
- temazepam $0
temazepam
$0 per unit
What this shows tasimelteon is the costliest in this class at $609.00/unit; generics in the same class run a fraction of that.
Generic availability vs other classes
70% of sleep medications have a generic available, ranking #13 of 22 therapeutic classes (the typical class sits near 74%).
Source: CMS NADAC generic-availability flags across all PlainMeds therapeutic classes. The dot is this class; the line is the cross-class median.
eszopiclone
Lunesta
Eszopiclone (Lunesta) is a medicine that helps you fall asleep and stay asleep.
View details →
lemborexant
Dayvigo
Dayvigo is a medicine that can help you fall asleep and stay asleep.
View details →
melatonin OTC
Melatonin
Melatonin is a hormone supplement that can help with sleep.
View details →
ramelteon
Rozerem
Ramelteon (Rozerem) is a prescription medicine that can help you fall asleep faster.
View details →
suvorexant
Belsomra
Belsomra is a prescription medicine used to treat insomnia.
View details →
tasimelteon
Hetlioz
Tasimelteon (Hetlioz) is a medicine that helps people with Non-24-Hour Sleep-Wake Disorder (Non-24) sleep better.
View details →
temazepam
Restoril
Temazepam is a medicine that helps you sleep.
View details →
triazolam
Halcion
Triazolam (Halcion) is a medication used for the short-term treatment of insomnia.
View details →
zaleplon
Sonata
Zaleplon (Sonata) is a medicine that helps you fall asleep faster.
View details →
zolpidem
Ambien
Zolpidem (Ambien) is a medication that helps you fall asleep faster.
View details →
Understanding the Sleep Category
The Sleep category currently lists 10 medications in this database, each drawn from FDA drug labels and grouped by therapeutic classification. Prescription and OTC sleep aids for insomnia, including benzodiazepine receptor agonists and melatonin receptor agonists. Clinical guidelines usually treat these medications as a reference set when weighing treatment options, switching strategies, or comparing safety profiles.
Within this category you'll find examples such as zolpidem, melatonin, temazepam, alongside 7 other entries. Each drug page links to the same underlying FDA data, labeled uses, adverse events reported to FAERS, documented interactions, warnings, and, where available, NADAC acquisition pricing from CMS. Over-the-counter and prescription options can sit in the same category but follow different regulatory pathways: OTC products have simplified labeling aimed at self-care, while prescription drugs include detailed monographs meant for clinicians. That distinction matters when comparing dosing, monitoring requirements, and contraindications.
Browsing a category is a research starting point, not a treatment recommendation. Effectiveness, tolerability, and cost for any individual patient depend on the specific condition, comorbidities, other medications, genetics, and insurance coverage, none of which can be inferred from a category list alone. FAERS report counts, recall history, and shortage status all evolve as new data is reported to the FDA, so the relative standing of drugs in this class can shift month to month. This page is for educational purposes only and is not medical advice, a licensed clinician is the right source for personalized guidance.
Explore other categories
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.